Security News > 2021 > March > Friday Squid Blogging: On SQUIDS

You will find that J.W. Ulm, a gene therapy specialist, has some serious concerns about these, LNPs. "At present, relatively little has been reported on the tissue localisation of the LNPs used to encase the SARS-CoV-2 spike protein-encoding messenger RNA, and it is vital to have more specific information on precisely where the liposomal nanoparticles are going after injection."

As the article notes for various reasons mRNA has been a failure for three decades or more.

Well unlike more traditional vaccines that have a more than half an average lifetime on the "Phase IV" testing clock thus are a fairly well understood quantity as far as long term effects in safety and efficacy are concerned We just do not have that for these new mRNA jabs for obvious reasons.

Well from the EMA documents leak, it would appear stability thus longevity as a viable jab is one such thus the obvious question "How many more?".

At the moment we realy only have specific information on the short term safety/efficacy and it does not appear on balance to favour mRNA jabs over Oxford Astra Zenica.

We have some indicative information for more traditional vaccines in the long term but not in any way for the mRNA jabs.

News URL

https://www.schneier.com/blog/archives/2021/03/friday-squid-blogging-on-squids.html